These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25565067)

  • 1. Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient.
    Roberts AW; Dusetzina SB; Farley JF
    J Comp Eff Res; 2015 Jan; 4(1):27-35. PubMed ID: 25565067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores.
    Suissa S; Moodie EE; Dell'Aniello S
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):459-468. PubMed ID: 27610604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands.
    Gardarsdottir H; Heerdink ER; Egberts AC
    Pharmacoepidemiol Drug Saf; 2006 May; 15(5):338-43. PubMed ID: 16496430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incident user design in comparative effectiveness research.
    Johnson ES; Bartman BA; Briesacher BA; Fleming NS; Gerhard T; Kornegay CJ; Nourjah P; Sauer B; Schumock GT; Sedrakyan A; Stürmer T; West SL; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):1-6. PubMed ID: 23023988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?
    Palmaro A; Boucherie Q; Dupouy J; Micallef J; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):544-553. PubMed ID: 28266748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A probabilistic bias analysis for misclassified categorical exposures, with application to oral anti-hyperglycaemic drugs.
    Arfè A; Nicotra F; Ghirardi A; Simonetti M; Lapi F; Sturkenboom M; Corrao G
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1443-1450. PubMed ID: 27594547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials.
    Asche CV; Luo W; Aagren M
    Curr Med Res Opin; 2013 Oct; 29(10):1287-96. PubMed ID: 23865725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic bias analysis in pharmacoepidemiology and comparative effectiveness research: a systematic review.
    Hunnicutt JN; Ulbricht CM; Chrysanthopoulou SA; Lapane KL
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1343-1353. PubMed ID: 27593968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does antidepressant medication use affect persistence with diabetes medicines?
    Caughey GE; Preiss AK; Vitry AI; Gilbert AL; Ryan P; Shakib S; Esterman A; McDermott RA; Roughead EE
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):615-22. PubMed ID: 23447430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage of routinely collected oncology clinical data with health insurance claims data--an example with aromatase inhibitors, tamoxifen, and all-cause mortality.
    Dore DD; Liang C; Ziyadeh N; Norman H; Bayliss M; Seeger JD
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():29-36. PubMed ID: 22552977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short look-back periods in pharmacoepidemiologic studies of new users of antibiotics and asthma medications introduce severe misclassification.
    Riis AH; Johansen MB; Jacobsen JB; Brookhart MA; Stürmer T; Støvring H
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):478-85. PubMed ID: 25601142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterpoint: the treatment decision design.
    Brookhart MA
    Am J Epidemiol; 2015 Nov; 182(10):840-5. PubMed ID: 26507307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods.
    Connolly JG; Schneeweiss S; Glynn RJ; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):665-670. PubMed ID: 30786103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
    Barner JC
    Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures.
    Corrao G; Ghirardi A; Segafredo G; Zambon A; Della Vedova G; Lapi F; Cipriani F; Caputi A; Vaccheri A; Gregori D; Gesuita R; Vestri A; Staniscia T; Mazzaglia G; Di Bari M;
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):859-67. PubMed ID: 24911392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: a simulation cohort study.
    Gamble JM; McAlister FA; Johnson JA; Eurich DT
    Value Health; 2012 Jan; 15(1):191-7. PubMed ID: 22264988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices.
    Luijken K; Spekreijse JJ; van Smeden M; Gardarsdottir H; Groenwold RHH
    Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):960-974. PubMed ID: 33899305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
    Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysing duration of episodes of pharmacological care: an example of antidepressant use in Danish general practice.
    Gichangi A; Andersen M; Kragstrup J; Vach W
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):167-77. PubMed ID: 16315340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence generation from healthcare databases: recommendations for managing change.
    Bourke A; Bate A; Sauer BC; Brown JS; Hall GC
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):749-54. PubMed ID: 27183900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.